Trial Profile
Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 25 Jun 2021
Price :
$35
*
At a glance
- Drugs Etoricoxib (Primary) ; Diclofenac
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 10 Jun 2021 Status changed from recruiting to withdrawn prior to enrolment.
- 08 Nov 2011 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database record.
- 19 Feb 2010 New trial record